Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

ALRN Aileron Therapeutics Inc

3,90

0,08 (2,09%)

Zuletzt aktualisiert: 20:08:08

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Aileron Therapeutics (NASDAQ:ALRN)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Aileron Therapeutics Charts.

Aileron Therapeutics (NASDAQ:ALRN)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Aileron Therapeutics Charts.

News Aileron Therapeutics Inc

Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million
Mittwoch 1 Mai 2024 (2 Tage vor) • GlobeNewswire Inc.

Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
Mittwoch 1 Mai 2024 (2 Tage vor) • GlobeNewswire Inc.

Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Montag 15 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

Aileron Therapeutics Announces CEO Transition
Dienstag 12 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 29 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event
Donnerstag 15 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 13 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Dienstag 6 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Montag 5 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024
Donnerstag 1 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mittwoch 31 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Aileron Therapeutics Inc News-Artikel

Euro vs Sterling

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen